Midostaurin in patients with indolent systemic mastocytosis: An open-label phase 2 trial

J Allergy Clin Immunol. 2018 Sep;142(3):1006-1008.e7. doi: 10.1016/j.jaci.2018.06.003. Epub 2018 Jun 8.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Female
  • Humans
  • Male
  • Mastocytosis, Systemic / drug therapy*
  • Middle Aged
  • Protein Kinase Inhibitors / therapeutic use*
  • Staurosporine / analogs & derivatives*
  • Staurosporine / therapeutic use
  • Treatment Outcome

Substances

  • Protein Kinase Inhibitors
  • Staurosporine
  • midostaurin

Associated data

  • ClinicalTrials.gov/NCT01920204